PACE Interim Impact Report
Details
| Contract Title: | PACE Interim Impact Report |
| Published Date: | Dec 10, 2025 |
| Notice Type: | Notice (AdditionalInformationNotice) |
| Value Banding: | High Value |
| Delivery Point: | United Kingdom |
Description:
PACE (Pathways to Antimicrobial Clinical Efficacy) is a £30 million initiative supporting and funding early-stage innovation in medicines and diagnostics, aimed at tackling AMR. It was established in September 2023 and is a collaboration between Innovate UK (IUK), LifeArc, and Medicines Discovery Catapult (MDC) - three leaders in the UK's health innovation and research community. PACE brings together the funding, resources, and partnerships to help innovators progress their early-stage antimicro...